Results 51 to 60 of about 38,906 (120)

A Susceptible Cell‐Selective Delivery (SCSD) of mRNA‐Encoded Cas13d Against Influenza Infection

open access: yesAdvanced Science, Volume 12, Issue 9, March 6, 2025.
A CRISPR/Cas13d system is designed for broad‐spectrum targeting of IAV, incorporating Cas13d mRNA and a tandem crRNA specific for conserved regions of the viral PA, NP, and M gene segments, respectively. This CRISPR/Cas13d system is delivered by a Susceptible Cell Selective Delivery (SCSD) system which targets sialic acid receptors and shows effective ...
Zhuanli Wu   +14 more
wiley   +1 more source

Efficient Gene Editing of CART Cells with CRISPR-Cas12a for Enhanced Antitumor Efficacy

open access: yes, 2020
Chimeric antigen receptor T (CART) cells are engineered with an artificial receptor which redirects T cells to recognize cancer cells expressing a particular surface antigen.
Elizabeth L. Siegler   +12 more
semanticscholar   +1 more source

High Nutritional Conditions Influence Feeding Plasticity in Pristionchus pacificus and Render Worms Non‐Predatory

open access: yesJournal of Experimental Zoology Part B: Molecular and Developmental Evolution, Volume 344, Issue 2, Page 94-111, March 2025.
Some nematodes exhibit mouth‐form polyphenism resulting in different feeding strategies including predation. In this study, Piskobulu and co‐workers investigate the influence of glucose supplementation on mouth‐form expression and find that higher glucose levels render worms non‐predatory.
Veysi Piskobulu   +5 more
wiley   +1 more source

Prediction and Validation of Native and Engineered Cas9 Guide Sequences.

open access: yesCold Spring Harbor Protocols, 2016
Cas9-based technologies rely on native elements of Type II CRISPR-Cas bacterial immune systems, including the trans-activating CRISPR RNA (tracrRNA), CRISPR RNA (crRNA), Cas9 protein, and protospacer-adjacent motif (PAM).
A. Briner, E. D. Henriksen, R. Barrangou
semanticscholar   +1 more source

Regulation of CRISPR trans-cleavage activity by an overhanging activator. [PDF]

open access: yesNucleic Acids Res
Yin N   +13 more
europepmc   +1 more source

DNA target binding-induced pre-crRNA processing in type II and V CRISPR-Cas systems. [PDF]

open access: yesNucleic Acids Res
Chen J   +6 more
europepmc   +1 more source

Expanding Cas12a Activity Control with an RNA G-Quadruplex at the 5' end of CRISPR RNA. [PDF]

open access: yesAdv Sci (Weinh)
Huang W   +8 more
europepmc   +1 more source

Molecular insights and rational engineering of a compact CRISPR-Cas effector Cas12h1 with a broad-spectrum PAM. [PDF]

open access: yesSignal Transduct Target Ther
Zheng W   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy